Anti-LSD (LSD-7543)
Anti-LSD (LSD-7543)
Product No.: L239
- -
- -
Clone LSD-7543 Target LSD Formats AvailableView All Product Type Hybridoma Monoclonal Antibody Alternate Names Lysergic acid diethylamide Isotype Mouse IgG1 κ Applications ELISA , Lateral Flow |
- -
- -
Antibody DetailsProduct DetailsProduct Concentration ≥1.0 mg/ml Purity >98% by SDS Page Formulation Formulated in phosphate buffered saline, pH 7.2 and contains 0.05% sodium azide. State of Matter Liquid Product Preparation This monoclonal antibody is purified by Protein A chromatography. Storage and Handling 2-8ºC Regulatory Status Research Use Only Country of Origin USA Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionSpecificity Anti-LSD (Clone LSD-7543) is specific for lysergic acid diethylamide (LSD). Background Lysergic acid diethylamide (LSD) is a powerful hallucinogenic substance that belongs to the psychedelic class of drugs. The substance primarily interacts with serotonin receptors in the brain, leading to profound changes in perception, mood, and cognition. While LSD is not considered physically addictive, its psychological effects can be intense, and users may experience "bad trips" characterized by anxiety and paranoia. Diagnostic testing for LSD use typically relies on urine or blood tests to detect the presence of the drug or its metabolites. However, due to the rapid metabolism of LSD, these tests may have a limited window of detection, making it challenging to confirm recent use. Additionally, LSD does not appear in standard drug screenings, necessitating specific tests when suspicion arises. Overall, the unique pharmacological properties of LSD pose challenges for diagnostic testing. Antigen DetailsResearch Area Drug of Abuse . Matched Pair . IVD Raw Material References & Citations1. Hwang KAJ, Saadabadi A. Lysergic Acid Diethylamide (LSD). StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. Link Technical Protocols |
Formats Available
